Oujiawan shares surge 46% in four days, then plunge; company warns of speculative risks
Oujiawan, a Chinese massage chair manufacturer, saw its stock surge 46.65% over four consecutive daily limit-up sessions from September 21-24, reaching 8.33 yuan per share. On September 27, the company issued a risk warning stating its health service robot business remains exploratory with no sales revenue. On September 28, the stock initially rose 9.6% before plunging 6.12% to 7.82 yuan. A company representative cited market speculation and urged investor caution.
IllustrationEditorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary covers the current reports
Cross-source coverage
Common ground
- Oujiawan's stock surged 46% in four days on hype about health service robots and elderly care, despite the company stating the business is exploratory with no revenue.
- The company's warning was transparent and honest, but it came after the frenzy had already caused losses for retail traders.
- The turnover rate of 13.49% on the reversal day shows momentum chasers and day traders, not long-term investors, drove the surge.
- Insiders at Oujiawan did not sell shares during the rally, which is unusual and commendable.
Points of contention
- Eastern Agent sees the warning as proof of China's responsible market system, while Regional Agent and Neutral Agent view it as reactive damage control after the fact.
- Regional Agent argues the system exploits small investors through information asymmetry and state-backed narratives, while Eastern Agent blames individual greed and lack of due diligence.
- Neutral Agent frames the event as a behavioral math problem of price detaching from value, while Eastern Agent emphasizes cultural and regulatory differences as key to market stability.
Blind spots
- All agents overlook the voices of the actual retail investors who lost money, focusing instead on ideological debates about systems and flags.
- The debate ignores how state-aligned media and social platforms amplified the hype narrative before the company's warning, influencing small investors with limited access to data.
- No one fully addresses why the company waited four days to issue a warning, rather than clarifying its position on day one of the surge.
WorldAttention’s read
Oujiawan's case is a clear example of speculative frenzy where a stock surged 46% on a story the company itself said wasn't real. The company's warning was honest and insiders didn't cash out, but it came too late to prevent losses for retail traders who bought into the hype. While Eastern Agent celebrates this as proof of China's stable market system, Regional Agent and Neutral Agent see it as reactive damage control and a behavioral failure. The real blind spot is that the debate ignores the human cost—retirees and small savers who lost money—and the role of media and social platforms in fueling the narrative. Ultimately, this isn't about which market system is better; it's a universal lesson that buying stocks on unconfirmed stories is gambling, not investing.
Reporting timeline
Oujiawan Stock Plunges After Four-Day Rally; Company Warns of Speculation
On September 28, shares of Oujiawan, a global leader in health and massage equipment, initially surged 9.6% following a four-day consecutive limit-up streak, reaching 9.13 yuan per share. However, the stock then experienced a sharp reversal, dropping approximately 6.12% to 7.82 yuan per share within minutes, with a turnover rate of 13.49%. A company representative, reached by a reporter posing as an investor, stated that the market situation is complex with many speculative concepts. The representative emphasized that the company's fundamentals have not significantly improved and that short-term prospects, including those related to robotics, remain highly uncertain, urging investors to be cautious. This warning echoes a previous company announcement clarifying that its health service robot business is still in an exploratory phase and does not involve humanoid robots, with outcomes remaining uncertain.
Read sourceOujiawan Responds to Intraday Stock Plunge, Citing Market Speculation and Uncertainty
Oujiawan, a global leader in health massage equipment that had surged for four consecutive trading days last week, saw its stock price initially rise 9.6% to 9.13 yuan per share at the open on September 28, before sharply reversing course. By 9:35 a.m., the stock had fallen to 7.82 yuan, a drop of approximately 6.12%, with a turnover rate of 13.49%. In response to the volatility, a company representative told a reporter posing as an investor that the current market situation is complex with many speculative concepts. The representative stated that the company's fundamentals have not significantly improved, and that short-term prospects in areas such as robotics and other fields remain highly uncertain. The company urged investors to be aware of the risks.
Read sourceOujiawei Warns Health Service Robot Business Still in Exploration Phase After Four-Day Stock Surge
Oujiawei (stock code: 002614) issued a risk warning on September 27 after its stock price surged 46.65% over four consecutive trading days, closing at 8.33 yuan per share with a total market capitalization of 5.196 billion yuan. The company stated that its health service robot business remains in an exploratory stage and has not yet entered the humanoid robot field, with significant uncertainty. It also noted that some health care products can be used in elderly care scenarios but account for a small portion of revenue, having limited impact on overall performance. Additionally, while some export business involves RCEP member countries, the overall benefit is limited and has not materially affected operating results. The stock experienced abnormal trading volatility on September 23 and 24, with cumulative closing price deviations exceeding 20%.
Show 3 older updatesHide older updates
Oujiawan Warns Health Service Robot Business in Early Stage After Four Consecutive Limit-Up Days
Beijing Business Today reports that Oujiawan (stock code 002614) issued a risk warning after its stock price surged approximately 46.65% over four consecutive trading days from September 21 to September 24, hitting the daily limit-up on each day. The stock closed at 8.33 yuan per share on September 24, giving it a total market capitalization of 5.196 billion yuan. The company stated that its health service robot business is still in an exploratory phase and has not yet involved humanoid robots, with significant uncertainty remaining. It also noted that some of its health care products can be used in elderly care scenarios, but their revenue contribution is low and has limited impact on overall performance. Additionally, while part of its export business involves RCEP member countries, the overall benefit is limited and has not materially affected operating results.
Read sourceOujiawan shares surge 46% in four days; company warns robot business is early stage
Oujiawan (stock code 002614) saw its share price hit the daily limit for four consecutive trading days from September 21 to 24, accumulating a gain of approximately 46.65%. On September 27, the company issued an abnormal stock price fluctuation announcement after the closing price deviation exceeded 20% over two consecutive trading days. The company clarified that its health service robot business is still in an early exploratory phase, does not involve humanoid robots, and has not generated any sales revenue to date, thus having no material impact on current or near-term performance. The company also disclosed that its controlling shareholders are transferring a 10% stake to Shanghai Yixin Private Fund Management Co. via a block trade. Oujiawan reported a net loss of 73.92 million yuan for the first half of 2026, despite a 16.14% revenue increase, due to a 71.79 million yuan foreign exchange loss and losses from non-core businesses. The company stated it will focus on core profitable operations and cut non-core projects. The stock's trailing P/E ratio is negative, significantly different from the industry average of 20.67 times.
Read sourceOujiawan Warns Health Service Robot Business Still Exploratory After Four Consecutive Limit-Up Days
Chinese massage chair manufacturer Oujiawan (stock code: 002614) issued a risk warning on September 27 after its stock price hit four consecutive daily limit-up gains, closing at 8.33 yuan per share with a total market capitalization of 5.196 billion yuan. The company stated that its health service robot business remains in an exploratory stage with significant uncertainties. It also noted that some of its health care products can be used in elderly care scenarios, but their revenue contribution is low and has limited impact on overall performance. Additionally, while some export business involves RCEP member countries, the overall benefit is limited and has not materially affected operating results. The warning was reported by Beijing Business Today and published on East Money's A-share company channel.